DAS
RIGL icon

Dynamic Advisor Solutions’s Rigel Pharmaceuticals RIGL Stock Holding History

Dynamic Advisor Solutions’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,250
Closed -$4K – 798
2021
Q2 		$4K Buy
+2,250
New +$84.9K ﹤0.01% 740

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dynamic Advisor Solutions's RIGL Position: Q1 2024 in Review

Dynamic Advisor Solutions sold out of Rigel Pharmaceuticals (RIGL) in Q1 2024, closing a stake of 2,129 shares — an estimated $29.4K sold.

Dynamic Advisor Solutions first reported a position in RIGL in Q3 2020 and held it in 14 quarters. The position peaked at $92K in Q2 2021. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2024.

  • Dynamic Advisor Solutions reported no remaining Rigel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 2,129 Rigel Pharmaceuticals shares in Q1 2024, an estimated $29.4K.
  • Dynamic Advisor Solutions first reported a position in Rigel Pharmaceuticals in Q3 2020 and held it in 14 quarters.
  • Dynamic Advisor Solutions's Rigel Pharmaceuticals position peaked at $92K in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q1 2024, filed 12 Apr 2024.